Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Page 1
Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
Sachdev V, Sharma K, Keteyian SJ, Alcain CF, Desvigne-Nickens P, Fleg JL, Florea VG, Franklin BA, Guglin M, Halle M, Leifer ES, Panjrath G, Tinsley EA, Wong RP, Kitzman DW; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and American College of Cardiology. Sachdev V, et al. Among authors: kitzman dw. J Am Coll Cardiol. 2023 Apr 18;81(15):1524-1542. doi: 10.1016/j.jacc.2023.02.012. Epub 2023 Mar 21. J Am Coll Cardiol. 2023. PMID: 36958952
Finally, critical gaps in implementation of exercise-based therapies for patients with HFpEF, including exercise setting, training modalities, combinations with other strategies such as diet and medications, long-term adherence, incorporation of innovative and more accessi …
Finally, critical gaps in implementation of exercise-based therapies for patients with HFpEF, including exercise setting, training modalitie …
Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
Sachdev V, Sharma K, Keteyian SJ, Alcain CF, Desvigne-Nickens P, Fleg JL, Florea VG, Franklin BA, Guglin M, Halle M, Leifer ES, Panjrath G, Tinsley EA, Wong RP, Kitzman DW; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and American College of Cardiology. Sachdev V, et al. Among authors: kitzman dw. Circulation. 2023 Apr 18;147(16):e699-e715. doi: 10.1161/CIR.0000000000001122. Epub 2023 Mar 21. Circulation. 2023. PMID: 36943925 Review.
Finally, critical gaps in implementation of exercise-based therapies for patients with HFpEF, including exercise setting, training modalities, combinations with other strategies such as diet and medications, long-term adherence, incorporation of innovative and more accessi …
Finally, critical gaps in implementation of exercise-based therapies for patients with HFpEF, including exercise setting, training modalitie …
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis.
Savitz ST, Leong T, Sung SH, Kitzman DW, McNulty E, Mishell J, Rassi A, Ambrosy AP, Go AS. Savitz ST, et al. Among authors: kitzman dw. Am Heart J. 2023 Feb;256:60-72. doi: 10.1016/j.ahj.2022.11.007. Epub 2022 Nov 11. Am Heart J. 2023. PMID: 36372246 Free PMC article.
CONCLUSIONS: Despite using a combination of detailed STS/ACC TVT Registry and electronic health record data, predicting short-term clinical and patient-centered outcomes after TAVR remains challenging. ...
CONCLUSIONS: Despite using a combination of detailed STS/ACC TVT Registry and electronic health record data, predicting short-term cl …
Echocardiography-Based Cardiac Structure Parameters for the Long-term Risk of End-Stage Kidney Disease in Black Individuals: The Atherosclerosis Risk in Communities Study.
Kou M, Hishida M, Mathews L, Kitzman DW, Shah AM, Coresh J, Solomon S, Matsushita K, Ishigami J. Kou M, et al. Among authors: kitzman dw. Mayo Clin Proc. 2022 Oct;97(10):1794-1807. doi: 10.1016/j.mayocp.2022.06.018. Mayo Clin Proc. 2022. PMID: 36202493
OBJECTIVE: To assess whether echocardiographic parameters of left ventricular (LV) structure and function relate to the long-term risk of incident end-stage kidney disease (ESKD). PATIENTS AND METHODS: We conducted a prospective cohort study analyzing 2137 Black participan …
OBJECTIVE: To assess whether echocardiographic parameters of left ventricular (LV) structure and function relate to the long-term ris …
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease.
Smeijer JD, Koomen JV, Kohan DE, McMurray JJV, Bakris GL, Correa-Rotter R, Hou FF, Kitzman DW, Makino H, Mayer G, Nowicki M, Perkovic V, Rossing P, Tobe S, Parving HH, de Zeeuw D, Heerspink HJL. Smeijer JD, et al. Among authors: kitzman dw. Clin Pharmacol Ther. 2022 Nov;112(5):1098-1107. doi: 10.1002/cpt.2721. Epub 2022 Aug 11. Clin Pharmacol Ther. 2022. PMID: 35892316 Free PMC article. Clinical Trial.
OATP1B1 gene polymorphisms are associated with significant between-patient variability in atrasentan plasma exposure and long-term efficacy and safety....
OATP1B1 gene polymorphisms are associated with significant between-patient variability in atrasentan plasma exposure and long-term ef …
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
Heerspink HJL, Xie D, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Perkovic V, Rossing P, Parving HH, de Zeeuw D; on behalf on the SONAR Investigators. Heerspink HJL, et al. Among authors: kitzman dw. J Am Soc Nephrol. 2021 Nov;32(11):2900-2911. doi: 10.1681/ASN.2021030391. Epub 2021 Sep 22. J Am Soc Nephrol. 2021. PMID: 34551995 Free PMC article. Clinical Trial.
BACKGROUND: Whether early reduction in albuminuria with atrasentan treatment predicts its long-term kidney-protective effect is unknown. METHODS: To assess the long-term effects on kidney outcomes of atrasentan versus placebo in the SONAR trial, we enrolled patients …
BACKGROUND: Whether early reduction in albuminuria with atrasentan treatment predicts its long-term kidney-protective effect is unkno …
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Koomen JV, Stevens J, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan DE, Makino H, McMurray JJV, Parving HH, Perkovic V, Tobe SW, de Zeeuw D, Heerspink HJL. Koomen JV, et al. Among authors: kitzman dw. Clin Pharmacol Ther. 2021 Jun;109(6):1631-1638. doi: 10.1002/cpt.2143. Epub 2021 Jan 5. Clin Pharmacol Ther. 2021. PMID: 33338269 Free PMC article. Clinical Trial.
We evaluated whether plasma exposure was associated with long-term outcomes for kidney protection and heart failure in the phase III SONAR trial (n = 3668) in type 2 diabetics with chronic kidney disease. ...Parametric time-to-event models were used to quantify the associa …
We evaluated whether plasma exposure was associated with long-term outcomes for kidney protection and heart failure in the phase III …
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Among authors: kitzman dw. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
BACKGROUND: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasen …
BACKGROUND: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist a …
Long-Term Effects of Randomization to a Weight Loss Intervention in Older Adults: A Pilot Study.
Houston DK, Miller ME, Kitzman DW, Rejeski WJ, Messier SP, Lyles MF, Kritchevsky SB, Nicklas BJ. Houston DK, et al. Among authors: kitzman dw. J Nutr Gerontol Geriatr. 2019 Jan-Mar;38(1):83-99. doi: 10.1080/21551197.2019.1572570. Epub 2019 Mar 8. J Nutr Gerontol Geriatr. 2019. PMID: 30849296 Free PMC article.
Randomized, controlled trials (RCTs) show intentional weight loss improves body composition and physical function in older adults; however, the long-term benefits (and risks) are unknown. We conducted a pilot study to assess the feasibility of recalling prior RCT participa …
Randomized, controlled trials (RCTs) show intentional weight loss improves body composition and physical function in older adults; however, …
A Sister's Sacrifice.
Kitzman DW. Kitzman DW. J Am Geriatr Soc. 2019 Mar;67(3):618-619. doi: 10.1111/jgs.15695. Epub 2018 Nov 29. J Am Geriatr Soc. 2019. PMID: 30499102 No abstract available.
34 results